Ajay Gupta, 59 is the Chief Scientific Officer and has served in that position since he joined the company in June of 2009. Dr. Gupta has been a member of Rockwell’s Scientific Advisory Board since November, 2005. From 2002 to 2009, Dr. Gupta was an Associate Professor of Medicine at UCLA and Charles Drew University Schools of Medicine in Los Angeles where he had an active nephrology practice. Dr. Gupta is the inventor of dialysate iron therapy using Soluble Ferric Pyrophosphate (SFP) as well as the inventor of intravenous (IV) iron therapy using slow continuous infusion of SFP. He has filed a number of patents in the areas of drugs, medical devices and diagnostic tests. Dr. Gupta earned his MBBS degree and completed his residency in Internal Medicine from All India Institute of Medical Sciences (AIIMS), New Delhi. In 1990, he completed a Nephrology Clinical/Research Fellowship from Washington University, St. Louis, Missouri. He has served on the faculty at Washington University, St. Louis; State University of New York, Syracuse; University of Alabama, Birmingham and Henry Ford Hospital, Detroit; MI. Dr. Gupta is the founder and Chairman of the Indian Society for Bone and Mineral Research; earned his MBBS degree and completed his residency in Internal Medicine for AII India Institute of Medical Sciences, New Delhi; has completed a clinical fellowship in Nephrology from Wayne State University, Detroit, Michigan and a research fellowship in Nephrology from Washington University, St. Louis, Missouri.